ISEYF yields 13333.33% · PFE yields 6.13%● Live data
📍 ISEYF pulled ahead of the other in Year 1
Combined, ISEYF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ISEYF + PFE for your $10,000?
Wi2Wi Corporation designs, integrates, and manufactures wireless technology solutions in the United States and internationally. It offers wireless connectivity solutions, such as multi-protocol, Wi-Fi, and MCU embedded Bluetooth modules; location and navigation products, including GNSS and GPS modules; and timing and frequency control products comprising clock oscillators, crystals, crystal filters, and RF and microwave filters. The company also provides rubber duck antennas, PCB antennas, and antenna connector cables. Its products are primarily used in Internet of Things (IoT), industrial IoT, avionics, space, military, defense, government, infrastructure, automotive, industrial, medical, home and building, retail, communications, mobile-radio, personal navigation devices, and consumer applications. The company sells its products to OEMs, enterprises, and distributors. Wi2Wi Corporation was founded in 2005 and is headquartered in San Jose, California.
Full ISEYF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.